Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.

Carmel T CollinsRobert A GibsonPeter J AndersonAndrew J McPheeThomas R SullivanJacqueline F GouldPhilip RyanLex W DoylePeter G DavisJudy E McMichaelNoel P FrenchPaul B ColditzKaren SimmerScott A MorrisMaria Makrides

Published in: BMJ open (2015)

Australian New Zealand Clinical Trials Registry: ACTRN12606000327583.

Keyphrases

preterm infants
high dose
clinical trial
low birth weight
low dose
stem cell transplantation
fatty acid
type diabetes
open label
randomized controlled trial
metabolic syndrome
study protocol
glycemic control